Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.04 CAD | -0.33% | +3.75% | -61.03% |
Chart calendar BriaCell Therapeutics Corp.
Upcoming events on BriaCell Therapeutics Corp.
Past events on BriaCell Therapeutics Corp.
2024-04-10 12:00 | American Association for Cancer Research Meeting - Abstract No:6753 |
2024-04-09 12:00 | American Association for Cancer Research Meeting - Abstract No:CT204 |
2024-04-09 12:00 | American Association for Cancer Research Meeting - Abstract No:CT206 |
2024-03-18 17:05 | Q2 2024 Earnings Release |
2024-01-30 10:00 | Annual General Meeting |
2023-12-14 17:10 | Q1 2024 Earnings Release |
2023-12-07 13:00 | San Antonio Breast Cancer Symposium |
2023-12-06 18:00 | San Antonio Breast Cancer Symposium |
2023-12-06 13:00 | San Antonio Breast Cancer Symposium |
2023-11-03 12:00 | Society for Immunotherapy of Cancer Meeting - Abstract Number: 419 |
2023-10-26 10:00 | Investor Meeting - Key Opinion Leader |
2023-10-25 12:00 | Q4 2023 Earnings Release |
2023-09-04 | Spin off |
2023-08-18 10:00 | Extraordinary Shareholders Meeting - Restructuring Vote |
2023-04-17 13:30 | American Association for Cancer Research Meeting - Abstract Number: CT143 |
2023-04-17 09:00 | American Association for Cancer Research Meeting - Abstract Number: 2310 |
2023-04-17 09:00 | American Association for Cancer Research Meeting - Abstract Number: 2310 |
2023-04-16 13:30 | American Association for Cancer Research Meeting - Abstract Number: 685 |
2023-04-16 13:30 | American Association for Cancer Research Meeting - Abstract Number: 685 |
2023-04-16 13:30 | American Association for Cancer Research Meeting - Abstract Number: 304 |
Annual results
Fiscal Period | July | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | 0,00 | -15,3 -15,7 2.58% | -23,3 -21,9 -6.06% | -34,4 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -26,8 -15,7 -70.86% | -20,3 -24,2 15.94% | -24,5 |
Net income Million USD | Released Forecast Spread | -0,43 | -26,8 -15,7 -70.86% | -20,3 -24,2 15.94% | -24,5 |
EPS USD | Released Forecast Spread | -0,09 | -1,73 -1,02 -69.61% | -1,30 -1,56 16.4% | -1,39 |
Announcement Date | 28/10/21 | 27/10/22 | 25/10/23 | - |
Quarterly results
Fiscal Period | July | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 |
EBIT Million USD | Released Forecast Spread | -3,93 -2,40 -63.85% | -4,84 -3,31 -46.43% | -4,23 -4,61 8.38% | -5,40 -5,20 -3.91% | -4,49 -5,46 17.87% | -5,68 -5,57 -1.97% | -7,71 -6,36 -21.16% | -8,50 -8,00 -6.29% | -9,83 -8,40 -17.02% | -7,90 | -8,20 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,87 -2,45 -57.76% | -4,84 -3,31 -46.43% | -15,7 -4,61 -241.42% | -1,11 -5,20 78.72% | -11,9 -5,46 -117.52% | -4,90 -5,47 10.46% | -2,42 -6,26 61.36% | 5,96 -2,80 312.82% | -11,3 -3,20 -254.18% | -9,40 | -9,70 |
Net income Million USD | Released Forecast Spread | -3,87 -2,45 -57.76% | -4,84 -3,31 -46.43% | -15,7 -4,61 -241.42% | -1,11 -5,20 78.72% | -11,9 -5,46 -117.52% | -4,90 -5,47 10.46% | -2,42 -6,26 61.36% | 6,00 -2,80 314.34% | -11,3 -3,20 -252.96% | -9,40 | -9,70 |
EPS USD | Released Forecast Spread | -0,24 -0,17 -45.45% | -0,32 -0,21 -52.38% | -1,02 -0,31 -234.43% | -0,07 -0,33 78.79% | -0,77 -0,36 -116.9% | -0,32 -0,36 9.86% | -0,14 -0,40 64.56% | 0,36 -0,18 300% | -0,71 -0,20 -255% | -0,55 | -0,46 |
Announcement Date | 14/03/22 | 13/06/22 | 27/10/22 | 14/12/22 | 15/03/23 | 14/06/23 | 25/10/23 | 14/12/23 | 18/03/24 | - | - |
Past sector events for BriaCell Therapeutics Corp.
2024-05-03 07:00 | GH RESEARCH PLC: Q1 2024 Earnings Release |
2024-05-02 16:05 | KURA ONCOLOGY, INC.: Q1 2024 Earnings Release |
2024-05-02 16:05 | ZYMEWORKS INC.: Q1 2024 Earnings Release |
2024-05-02 16:02 | ARDELYX, INC.: Q1 2024 Earnings Release |
2024-05-02 16:01 | LONGBOARD PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
2024-05-02 16:01 | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
2024-05-02 16:00 | ULTRAGENYX PHARMACEUTICAL INC.: Q1 2024 Earnings Release |
2024-05-02 11:00 | GENMAB A/S: Q1 2024 Earnings Release |
2024-05-02 07:00 | GERON CORPORATION: Q1 2024 Earnings Release |
2024-05-02 07:00 | AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BCT Stock
- Calendar BriaCell Therapeutics Corp.